Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-12 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-12 |
mRNA | PIDD1 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-12 |
mRNA | RAVER1 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-12 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-12 |
mRNA | ZNF345 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-12 |
mRNA | NUDT3 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-12 |